Misonix Inc
MSON
Market Cap$0
Close$
$28.66
8% upside
Current Fair Value
8% upsideUndervalued by 8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $14.75 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.99 |
| Beta | 1.35 |
| Outstanding Shares | 17,226,181 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -26.9 |
|---|---|
| PEG | 56.51 |
| Price to Sales | 6.64 |
| Price to Book Ratio | 3.79 |
| Enterprise Value to Revenue | 0.2 |
| Enterprise Value to EBIT | -1.34 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 3.1 |
| Debt to Equity | 0.34 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Misonix Inc
254 employeesMisonix, Inc. is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells BoneScalpel and SonaStar, which facilitate precise bone sculpting and removal ...